This project deals with IgE-mediated human allergic responses to mouse urinary protein (MUP) which is a major human allergen. SUB- PROJECT ONE: IMMUNOREGULATION WITH DEFINED MOUSE ALLERGEN. The extensive knowledge of the genetics and structure of MUP and the closely related rat alpha2 euglobulin (a2Ug) will be exploited to further knowledge of mechanisms and immunotherapy in human IgE mediated allergy. It will be demonstrated that epitopes that are presented to T cells and that bind to IgE antibody are widely shared in this complex family of proteins. Immunoreactive fragments of MUP will be selected, synthesized and screened for immunoregulatory potential (inhibition of T cell activation at the antigen presentation level, generation of supressor T cells, inhibition of in vitro IgE antibody synthesis). These fragments will be tested for binding to IgE antibody and in vivo activity (skin test and bronchial reactivity). Double-blind trials will then be set up to test these fragments for efficacy in the immunotherapy of human occupational allergy to mice. IgE and IgG antibody responses, generation of supressor T cells, skin test and bronchial reactivity and clinical scores will be used to evaluate response. SUB-PROJECT TWO: IMMUNOLOGY AND EPIDEMIOLOGY OF OCCUPATIONAL ALLERGY TO MICE. IgE antibody binding will be tested in a selected population of workers to verify the importance of MUP in human allergy. This will be followed by a cross-sectional survey of existing employees for the presence and severity of allergy and levels of IgG and IgE antibody to MUP and other minor allergens such as albumin. All new workers who are hired will be studied prospectively for factors that will predict allergy. HLA typing will establish a link between IgE antibody and immune response genes. Systematic sampling of air and dust in various work locations will be correlated with such factors as ventilation rates, filter systems and types of caging. The level of allergen in the air will be compared with worker's allergic symptoms and the results of bronchial challenge with MUP.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI024848-06
Application #
3791077
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Xiang, Shi-Hua; Finzi, Andrés; Pacheco, Beatriz et al. (2010) A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol 84:3147-61
Borish, L; Mascali, J J; Klinnert, M et al. (1994) SSC polymorphisms in interleukin genes. Hum Mol Genet 3:1710
Matz, J; Williams, J; Rosenwasser, L J et al. (1994) Granulocyte-macrophage colony-stimulating factor stimulates macrophages to respond to IgE via the low affinity IgE receptor (CD23). J Allergy Clin Immunol 93:650-7
Borish, L; Dishuck, J; Cox, L et al. (1993) Sezary syndrome with elevated serum IgE and hypereosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 92:123-31
Ohman Jr, J L; Sparrow, D; MacDonald, M R (1993) New onset wheezing in an older male population: evidence of allergen sensitization in a longitudinal study. Results of the normative aging study. J Allergy Clin Immunol 91:752-7
Joseph, B Z; Routes, J M; Borish, L (1993) Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. Inflammation 17:361-70
Borish, L; Mascali, J J; Dishuck, J et al. (1992) Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol 149:3078-82
Williams, J; Johnson, S; Mascali, J J et al. (1992) Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 149:2823-9
Joseph, B Z; Sustiel, A M; Borish, L (1992) Neutrophils from asthmatics exhibit diminished responsiveness to 2-chloroadenosine which is reversed by theophylline. Evidence for a cyclic-AMP-independent pathway on human neutrophils. Inflammation 16:101-16
Borish, L; King, M S; Mascali, J J et al. (1992) Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation 16:471-84

Showing the most recent 10 out of 11 publications